Allergan is recalling one lot of birth-control pills — or 170,000 packs — because the first four pills in each 28-pill pack are inactive, placing women at risk of pregnancy.

One lot of Taytulla physician sample packs (marked lot #5620706 Exp. May 2019) contained the out-of-order pills, the company said. It learned about the error from a doctor who reported it.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • In the current hyper-partisan environment, I can only suggest that Allergan needs to find if it has “a hardened Republican in QA” who also opposes the concept of birth control. That would explain, “this little mix-up.”

    Justify, absolutely not but it’s a nifty conspiracy theory……

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy